Efficacy and safety of a modified Vaccinia Ankara-NP+M1 vaccine combined with QIV in people aged 65 and older: a randomised controlled clinical trial (INVICTUS)
<br><strong>Background: </strong>Pre-existing T cell responses to influenza have been correlated with improved clinical outcomes in natural history and human challenge studies. We aimed to determine the efficacy, safety and immunogenicity of a T-cell directed vaccine in older peopl...
| 主要な著者: | , , , , , , , , , , , , |
|---|---|
| その他の著者: | |
| フォーマット: | Journal article |
| 言語: | English |
| 出版事項: |
MDPI
2021
|